Heartflow (NASDAQ:HTFL) Hits New 12-Month High – Here’s Why

Heartflow, Inc. (NASDAQ:HTFL)’s share price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $51.36 and last traded at $51.2120, with a volume of 76614 shares. The stock had previously closed at $50.43.

Analysts Set New Price Targets

A number of research firms have recently commented on HTFL. Weiss Ratings upgraded Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Canaccord Genuity Group increased their price objective on shares of Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. Stifel Nicolaus lifted their price objective on Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a report on Friday, August 14th. Freedom Capital upgraded Heartflow to a “strong-buy” rating in a research report on Tuesday, June 30th. Finally, Benchmark reissued a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Heartflow presently has an average rating of “Moderate Buy” and a consensus target price of $43.43.

Heartflow Stock Performance

The firm has a market capitalization of $4.37 billion and a PE ratio of -27.51. The business’s fifty day simple moving average is $32.90 and its 200-day simple moving average is $29.39.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million for the quarter. The company’s quarterly revenue was up 47.7% on a year-over-year basis. Sell-side analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Insider Transactions at Heartflow

In related news, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $41.23, for a total value of $380,099.37. Following the completion of the transaction, the insider owned 86,459 shares in the company, valued at approximately $3,564,704.57. This trade represents a 9.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 38,900 shares of the business’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total value of $1,361,500.00. Following the transaction, the chief executive officer directly owned 457,935 shares in the company, valued at approximately $16,027,725. This represents a 7.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 191,271 shares of company stock valued at $7,089,136. 7.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd bought a new stake in Heartflow during the 4th quarter valued at $27,000. Russell Investments Group Ltd. purchased a new position in Heartflow in the fourth quarter worth $45,000. Legal & General Group Plc purchased a new stake in shares of Heartflow during the third quarter worth about $59,000. Essential Partners LLC purchased a new position in shares of Heartflow in the first quarter worth $57,000. Finally, Strs Ohio purchased a new stake in Heartflow during the 4th quarter valued at about $99,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.